Elena Masselli: Can Statins Enhance Peginterferon Therapy in MPNs?
Elena Masselli, Full Professor of Human Anatomy at the University of Parma and Consultant Hematologist at the University Hospital of Parma, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
“Thrilled to share our commentary recently published in Blood Advances on the paper by Professor Hans Hasselbalch’s group exploring the clinically relevant synergy between peginterferon and statins in patients with myeloproliferative neoplasms.
Our article discusses the signalling pathways that may contribute to the synergistic effects of these treatments.
We are truly honoured to have received such positive feedback from the authors!
Take a look and let us know your thoughts!”
Title: Are statins interferon’s best friend? Mechanistic insights
Authors: Giacomo Maria Cerreto, Cecilia Carubbi, Marco Vitale, Elena Masselli
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters